AMBUJACEM - IntraDay Trade Analysis with Live Signals
Last Updated Time : 20 Dec 25, 07:02 am
Back to IntraDay Trade ListIntraDay Trade Rating: 3.5
| Stock Code | AMBUJACEM | Market Cap | 1,33,577 Cr. | Current Price | 540 ₹ | High / Low | 625 ₹ |
| Stock P/E | 26.2 | Book Value | 206 ₹ | Dividend Yield | 0.37 % | ROCE | 8.80 % |
| ROE | 8.77 % | Face Value | 2.00 ₹ | DMA 50 | 553 ₹ | DMA 200 | 561 ₹ |
| Chg in FII Hold | -1.52 % | Chg in DII Hold | 0.92 % | PAT Qtr | 1,571 Cr. | PAT Prev Qtr | 855 Cr. |
| RSI | 41.9 | MACD | -4.04 | Volume | 8,52,055 | Avg Vol 1Wk | 11,52,700 |
| Low price | 455 ₹ | High price | 625 ₹ | PEG Ratio | 1.26 | Debt to equity | 0.02 |
| 52w Index | 50.2 % | Qtr Profit Var | 214 % | EPS | 20.0 ₹ | Industry PE | 33.2 |
📊 Analysis: AMBUJACEM trades at ₹540, below both DMA 50 (₹553) and DMA 200 (₹561), reflecting short-term weakness. RSI at 41.9 is neutral-to-weak, while MACD (-4.04) confirms bearish momentum. Volume (8.52L vs 11.52L avg) is lower than average, limiting intraday strength. Fundamentals show strong quarterly profit growth (+214%) and low debt-to-equity (0.02), but efficiency metrics (ROCE 8.8%, ROE 8.77%) remain modest. Suitable for cautious intraday trades with tight stop-losses.
- 💹 Optimal Buy Price: ₹535–545 (near support zone)
- 🎯 Profit-Taking Levels: ₹555 (first resistance), ₹565 (next resistance)
- 🛡️ Stop-Loss: Below ₹530 (to protect against breakdown)
- ⏱️ Exit if Holding: Exit intraday if price fails to sustain above ₹535 or if RSI slips below 40 with MACD staying negative despite institutional support.
Positive
- ✅ Quarterly profit growth (+214%) shows strong operational performance.
- ✅ Low debt-to-equity 0.02 ensures financial stability.
- ✅ DII holding increased (+0.92%), showing domestic institutional support.
- ✅ 52w Index 50.2% reflects relative strength in the sector.
Limitation
- ⚠️ Price below DMA 50 & 200, confirming short-term weakness.
- ⚠️ RSI near neutral (41.9), limiting momentum strength.
- ⚠️ MACD negative (-4.04), confirming bearish sentiment.
- ⚠️ FII holding reduced (-1.52%), showing foreign investor caution.
Company Negative News
- ❌ Weak technicals with price trading below key moving averages.
- ❌ Lower trading volume compared to 1-week average.
Company Positive News
- 🌟 PAT growth from ₹855 Cr. to ₹1,571 Cr. in latest quarter.
- 🌟 Dividend yield 0.37% supports investor sentiment.
Industry
- 🏗️ Industry PE at 33.2 vs AMBUJACEM PE 26.2 shows relative undervaluation.
- 🏗️ Cement sector remains cyclical but supported by infrastructure demand.
Conclusion
📌 AMBUJACEM is a moderate intraday candidate with strong fundamentals but weak technicals. Traders may attempt scalps near ₹535–545 with profit exits around ₹555–565, while maintaining a disciplined stop-loss below ₹530.
Would you like me to extend this into a cement sector peer benchmarking overlay so you can compare AMBUJACEM against other large-cap cement stocks for intraday rotation opportunities?
Back to IntraDay Trade ListNIFTY 50 - Today Top Intraday Trade Stock Picks
NEXT 50 - Today Top Intraday Trade Stock Picks
MIDCAP - Today Top Intraday Trade Stock Picks
SMALLCAP - Today Top Intraday Trade Stock Picks